Latest Breaking News On - Center named patient program - Page 1 : comparemela.com

Company’s priority oncology clinical programs continue to advance toward key milestones Additional clinical trial site now open at University of Nebraska for Phase 2 study of Ampligen® for. | June 12, 2023

United statesSouth africaUniversity of nebraska medical centerSouth africanThomask equelsKelsey kluteRintatolimod ampligenErasmus medical centerRoswell park comprehensive cancer centerImmunotech incGabrail cancer research centerEarly access programNetherlands at erasmus medical centerCompany on twitterUniversity of nebraskaPancreas club meeting